
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    Okay, I will analyze the provided list of highly expressed markers from a single-cell cluster in a human large intestine dataset to identify the cell type.<br><br>**Step 1: List the Key Functional Markers**<br><br>This cluster expresses several genes related to neural function, cell adhesion, and myelination:<br><br>*   **PLP1 (Proteolipid Protein 1):** A major structural component of myelin, essential for the formation and maintenance of the myelin sheath that insulates axons.<br>*   **SOX10 (SRY-Box Transcription Factor 10):** A transcription factor critical for the development and maintenance of neural crest-derived cells, including glial cells like Schwann cells and oligodendrocytes, and is involved in regulating myelin gene expression.<br>*   **FOXD3 (Forkhead Box D3):** Another transcription factor involved in neural crest development and the specification of various cell lineages, including glial cells.<br>*   **L1CAM (L1 Cell Adhesion Molecule):** A cell adhesion molecule involved in neuron-neuron and neuron-glia interactions, neurite outgrowth, and myelination.<br>*   **NRXN1 (Neurexin 1), NRXN3 (Neurexin 3):** Presynaptic cell adhesion molecules that interact with postsynaptic neuroligins to form synapses. In the context of glia, they are involved in glia-neuron communication and synapse modulation.<br>*   **CADM2 (Cell Adhesion Molecule 2):** A synaptic cell adhesion molecule involved in synapse formation and maintenance.<br>*   **SLITRK2 (SLIT and NTRK Like Family Member 2):** A transmembrane protein involved in neuronal development and synapse formation.<br>*   **CHL1 (Cell Adhesion Molecule L1 Like):** A cell adhesion molecule involved in neuronal development, axon guidance, and myelination.<br>*   **TENM3 (Teneurin Transmembrane Protein 3):** A transmembrane protein involved in neural circuit assembly and synapse formation.<br>*   **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** A receptor protein tyrosine phosphatase expressed in the nervous system, involved in neuronal development and glial function, including myelination.<br>*   **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for neurturin, involved in the survival and development of various neuronal populations and their associated glia.<br>*   **FLRT1 (Fibronectin Leucine Rich Transmembrane Protein 1):** A transmembrane protein involved in cell adhesion and signaling, expressed in the nervous system.<br>*   **SPP1 (Secreted Phosphoprotein 1):** Involved in cell adhesion, migration, and immune responses. Can be expressed by Schwann cells in certain states, such as injury or development.<br><br>**Step 2: List the Key Cell Type Markers**<br><br>The most prominent cell type markers in this list point towards glial cells of the peripheral nervous system:<br><br>*   **PLP1:** A canonical marker for myelinating glial cells (oligodendrocytes in CNS, Schwann cells in PNS). Its high expression is a strong indicator of myelination.<br>*   **SOX10:** A definitive marker for neural crest-derived glial cells, including Schwann cells and satellite glial cells.<br>*   **FOXD3:** Another marker for neural crest derivatives, including Schwann cells.<br>*   **L1CAM, NRXN1, NRXN3, CADM2, SLITRK2, CHL1, TENM3, PTPRZ1, GFRA2, FLRT1:** While many of these are involved in neuronal function, their co-expression with PLP1, SOX10, and FOXD3 in the peripheral nervous system context is characteristic of Schwann cells, which intimately interact with axons and form myelin.<br><br>**Step 3: Cross-reference Known Databases**<br><br>Cross-referencing these markers (especially PLP1, SOX10, FOXD3) in scRNA-seq databases like the Human Cell Atlas, PanglaoDB, and CellMarker, as well as relevant literature on the peripheral nervous system and large intestine innervation, consistently identifies this marker profile with **Schwann cells**. PLP1 is a well-established marker for myelinating Schwann cells. SOX10 and FOXD3 are markers for the broader Schwann cell lineage. The presence of numerous neuron-interaction molecules further supports a cell type closely associated with axons.<br><br>**Step 4: Determine the Most Probable General Cell Type**<br><br>Based on the strong expression of key glial markers (PLP1, SOX10, FOXD3) and numerous genes involved in neuron-glia interaction and myelination, the most probable general cell type is **Glial cells**, specifically those associated with the peripheral nervous system found within the large intestine tissue.<br><br>**Step 5: Identify the Top 3 Most Probable Sub Cell Types**<br><br>Within the peripheral nervous system, the main glial cell types are Schwann cells and Satellite glial cells. Schwann cells are further categorized into myelinating and non-myelinating (Remak) Schwann cells.<br><br>1.  **Myelinating Schwann Cells:** These cells form the myelin sheath around large caliber axons in the PNS. They are characterized by high expression of myelin structural genes like PLP1, MPZ, and PMP22, as well as transcription factors like SOX10 and FOXD3. The high ranking of **PLP1** in the provided list is a strong indicator of this subtype.<br>2.  **Non-myelinating (Remak) Schwann Cells:** These cells ensheath multiple small caliber axons but do not form myelin sheaths. They express SOX10 and FOXD3, and neuron-interaction markers, but typically have low or absent expression of myelin structural genes like PLP1.<br>3.  **Satellite Glial Cells:** These cells surround neuronal cell bodies in ganglia. They express SOX10 and GFAP but are distinct from Schwann cells and do not express myelin markers like PLP1.<br><br>Given the high expression of **PLP1**, the most likely subtype is **Myelinating Schwann Cells**.<br><br>**Step 6: Provide a Concise Summary of Your Analysis**<br><br>The single-cell cluster from the human large intestine dataset is characterized by the high expression of canonical Schwann cell markers, including PLP1, SOX10, and FOXD3. The presence of PLP1, a key component of myelin, strongly indicates a myelinating cell type. Furthermore, the cluster expresses numerous genes involved in neuron-glia adhesion and interaction (e.g., L1CAM, NRXN1, CADM2, PTPRZ1), consistent with the function of Schwann cells in supporting and interacting with peripheral axons. Based on this marker profile, the cluster is confidently identified as **Myelinating Schwann Cells**.<br><br>FINAL ANNOTATION COMPLETED.
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Glial cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Myelinating Schwann Cells</li><li>Non-myelinating (Remak) Schwann Cells</li><li>Satellite Glial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results demonstrate a thorough and scientifically accurate analysis of the marker genes, correctly identifying the cluster as glial cells, specifically myelinating Schwann cells. Here‚Äôs a detailed evaluation:<br><br>### Strengths:<br>1. **Correctness of Annotations**: The annotation is scientifically sound. Key markers like **PLP1**, **SOX10**, and **FOXD3** are accurately interpreted as indicative of Schwann cells, particularly myelinating Schwann cells. The inclusion of **NRXN1**, **CADM2**, and **L1CAM** further supports the neuron-glia interaction context, which is characteristic of Schwann cells.<br>2. **Balanced Consideration of Markers**: The analysis does not overly rely on a single marker but integrates multiple markers to build a coherent picture. For example, **PLP1** (myelination) is paired with **SOX10** (glial lineage) and **L1CAM** (neuron-glia interaction), providing a holistic view.<br>3. **Comprehensive View**: The annotation captures the general cell type (glial cells) and correctly narrows it down to myelinating Schwann cells as the most probable subtype. It also considers alternative subtypes (non-myelinating Schwann cells, satellite glial cells) but justifies the primary annotation with strong evidence.<br>4. **Rank Consideration**: The analysis implicitly considers marker rank by prioritizing **PLP1**, **SOX10**, and **FOXD3**, which are highly expressed and biologically significant for Schwann cells.<br><br>### Weaknesses:<br>1. **Peripheral vs. Enteric Nervous System Context**: The analysis assumes the glial cells are part of the peripheral nervous system (PNS) but does not explicitly address the possibility of enteric glial cells (EGCs), which are also present in the large intestine. While EGCs share some markers with Schwann cells (e.g., **SOX10**), they typically lack **PLP1**. This oversight is minor but worth noting.<br>2. **SPP1 Interpretation**: **SPP1** is mentioned as a Schwann cell marker in certain states, but its role in immune responses or other contexts (e.g., fibrosis) is not explored. This could hint at a rare or activated Schwann cell state, but the analysis does not delve deeper.<br>3. **Lack of Negative Markers**: The analysis does not explicitly rule out other glial subtypes (e.g., oligodendrocytes, which express **PLP1** but are CNS-specific) using negative markers, though the tissue origin (large intestine) makes this unlikely.<br><br>### Overall:<br>The annotation is highly accurate and well-reasoned, with only minor oversights. The strength of the marker evidence and the logical flow of the analysis justify the final annotation.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    